Science and Technology
AI-Powered Moderna Cancer Vaccine Shows Promise in Phase 3 Trial, Elon Musk Reacts
Moderna and Merck report positive Phase 3 results for an AI-assisted personalised mRNA cancer vaccine for melanoma, as Elon Musk calls…
Topic
mrna technology
3 stories
Lifestyle
Moderna, Merck mRNA Cancer Vaccine Shows Positive Phase 3 Results in Melanoma Trial
Moderna and Merck's personalised mRNA cancer vaccine with Keytruda shows positive Phase 3 results, reducing melanoma recurrence and spread…
Lifestyle
World's first mRNA flu vaccine approved: What it means for adults over 50
The US FDA has approved the world's first mRNA-based seasonal influenza vaccine for adults aged 50 and above. Here's how the vaccine works…
